Williams syndrome

[MIM 194 050]

(Williams-Beuren syndrome, 7q11.23 deletion , 7q11.23 monosomy )

Sporadic: prevalence 1/7,500. De novo deletion, of variable size, (26 to 28 genes) of chromosome 7q11.23. This mutation causes among others an elastin (ELN gene) deficiency in arterial walls: this arteriopathy due to lack of elastin causes hyperplasia of the smooth muscle in the arterial media. 

Association to varying degrees of:

-         supravalvular-aortic stenosis (45-75%); either hourglass (75%) stenosis or stenosis of a long segment of the aorta with secondary hypertrophy of LV and often the RD

-        distal pulmonary stenosis in 40%: this stenosis may be critical before the age of 1 year but seems to be improving with age due to the lower pressures in the pulmonary arterial system

-        coronary lesions: ostial anomaly,  winding coronary arteries, localized coronary dilations, secondary atheromatosis; severe coronary artery lesions may be present in the absence of significant valvular lesions

-        stenosis at the level of the bifurcation of large arteries: risk of hypertension of renal origin, stenosis of the thoracic aorta (middle aortic syndrome), sometimes stenosis of the carotid or cerebral arteries

-        structural heart abnormalities: VSD, aortic valve anomalies (adhesions at the sinotubular junction, bicuspid valve) especially in case of supravalvular stenosis (50%), mitral valve prolapse

-        risk of sudden death, particularly in case of anesthesia, which appears to be linked to the presence of a long QT (13.6% of cases)


Treatments: antihypertensive (calcium antagonists, β-blockers, minoxidil), treatment for the long Qt if present

Proposal for an anesthetic risk classification:


low

moderate

important

age > 20 years

arterial hypertension

age < 3 years

previous cardiovascular problem

normal ECG

-        moderate supravalvular aortic stenosis 
(< 40 mmHg gradient)


or 


- moderate stenosis of a branch of the pulmonary artery

       severe supravalvular aortic stenosis (> 40 mmHg gradient)
and a signs of left ventricular hypertrophy at ECG

echocardiography:
moderate supravalvular aortic or pulmonary stenosis


       moderate obstruction to ejection for both ventricles

       important obstruction to ejection for both ventricles

few extracardiac anomalies; no renal artery stenosis

       stenosis of the renal artery

-        diffuse involvement of the thoracic aorta

-        involvement of coronary arteries



- QTc > 450 msec but < 500 msec

-        QTc > 500 msec or

-  presence of arhythmias on preop ECG


- upper airway anomalies

- gastroesophageal reflux, pulmonary involvement

-         LV or RV hypertrophy or

-        ischemia signs on ECG


Anesthetic implications: 

preoperative: ECG and recent echocardiography. 

Perianesthetic: ECG with 5 derivations; to be considered as at high risk for myocardial ischemia: avoid tachycardia, maintain sinus rhythm, preserve preload (avoid prolonged fasting and any hypovolemia) and afterload (avoid hypotension), maintain contractility and avoid any increase in lung resistance (hypoxemia, hypercarbia, ventilation pressures). Avoid high concentrations of sevoflurane; ideal: ketamine, etomidate, morphine, small doses of propofol. 

Cardiac complications (11 % in a series), sudden death with very difficult resuscitation (cfr aortic stenosis and HVG). No risk of malignant hyperthermia.

One team has reported that, in case of mild or severe risk (see the table), the risk of systolic hypotension at induction and of the associated cardiac complications could be diminished by IV induction and rapid (even prophylactic) administration of a vasopressor.


References : 


Updated: January 2022